Beverley A Moore (Beverley Moore)

Publication Activity (10 Years)

Years Active: 2019-2019
Publications (10 Years): 2

Top Topics

Ulcerative Colitis

Endothelial Cells

Electronic Health Record

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

BA Moore Pharmaceutical Consulting, LLC

University of Calgary (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

BA Moore Pharmaceutical Consulting, LLC Jul 01 2017

United States

President

Education History

University of Calgary

Canada

PHD :: Medicine, Division of Gastroenterology

Publications

Carl L Manthey, Beverley A Moore, Yanqing Chen, Matthew J Loza, Xiang Yao, Hao Liu, Stanley M Belkowski, Holly Raymond-Parks, Paul J Dunford, Francisco Leon, Jennifer E Towne, Scott E Plevy
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis. PloS one 14 (11) (2019)
Fang Shen, Akash H Verma, Amy Volk, Brian Jones, Bianca M Coleman, Matthew J Loza, Ravi Malaviya, Beverley A Moore, Daniel Weinstock, M Merle Elloso, Sarah L Gaffen, Tatiana Ort
Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in Mice. Journal of immunology (Baltimore, Md. : 1950) 202 (7) (2019)